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Abstract
Background: This study aimed to compare relationships between height- or weight-adjusted appendicular skeletal
muscle mass (ASM/Ht2 or ASM/Wt) and risk factors for cardiometabolic diseases or osteoporosis in Japanese men
and women.
Methods: Subjects were healthy Japanese men (n = 583) and women (n = 1218). The study population included a
young group (310 men and 357 women; age, 18–40 years) and a middle-aged and elderly group (273 men and
861 women; age, ≥41 years). ASM was measured by dual-energy X-ray absorptiometry. The reference values for
class 1 and 2 sarcopenia in each sex were defined as values one and two standard deviations below the sex-specific
means of the young group, respectively.
Results: The reference values for class 1 and 2 sarcopenia defined by ASM/Ht2 were 7.77 and 6.89 kg/m2 in men and 6.
06 and 5.31 kg/m2 in women, respectively. The reference values for ASM/Wt were 35.0 and 32.0% in men and 29.6 and
26.4% in women, respectively. In both men and women, ASM/Wt was negatively correlated with higher triglycerides
(TG) and positively correlated with serum high-density lipoprotein cholesterol (HDL-C), but these associations were not
found in height-adjusted ASM. In women, TG, systolic blood pressure, and diastolic blood pressure in sarcopenia
defined by ASM/Wt were significantly higher than those in normal subjects, but these associations were
not found in sarcopenia defined by ASM/Ht2. Whole-body and regional bone mineral density in sarcopenia
defined by ASM/Ht2 were significantly lower than those in normal subjects, but these associations were not
found in sarcopenia defined by ASM/Wt.
Conclusions: Weight-adjusted definition was able to identify cardiometabolic risk factors such as TG and
HDL-C while height-adjusted definition could identify factors for osteoporosis.
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Background
“Sarcopenia” refers to a reduction in muscle mass and
function with age [1] and leads to physical disabilities
[2, 3], falls [2], and osteoporosis [4]. Sarcopenia also
increases the risk of developing chronic disorders,
including cardiovascular diseases (CVD) [5] and type
2 diabetes [6].
Although sarcopenia is often defined by relative
muscle mass, different methods for normalizing values,
such as by adjusting for height (Ht) and body weight
(Wt), have been widely reported. Baumgartner et al.
previously defined sarcopenia by height-adjusted ap-
pendicular skeletal muscle mass (ASM/Ht2, kg/m2) in a
study involving Hispanic and non-Hispanic white men
and women [2]. They reported that sarcopenia was
significantly associated with self-reported physical disabil-
ity in both sexes, independently of ethnicity, age, morbid-
ity, obesity, income, and hearth condition. In contrast,
Janssen et al. defined sarcopenia by weight-adjusted ASM
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(ASM/Wt × 100, %) in a study of non-Hispanic white
people, non-Hispanic black people, and Mexican Ameri-
cans [7]. They also reported that the age-related decrease
of relative muscle mass is significantly and independently
associated with functional impairment and disability, par-
ticularly in older women.
With regard to Asian populations, Hong et al. investi-
gated the association of sarcopenia defined by height-
adjusted ASM and sites of fragility fractures in Chinese
elderly [8]. Logistic regression analyses in that study re-
vealed that lower height-adjusted ASM was associated
with an increased risk of hip fracture both in men and
women. In elderly Korean people, height-adjusted ASM
was positively correlated with bone mineral density
(BMD), and a strong correlation was found between sar-
copenia and osteoporosis with risk of bone fracture [9].
Park et al. reported that CVD prevalence was positively
associated with sarcopenia defined by weight-adjusted
ASM in men after adjusting for CVD risk factors, but no
such association was found in women [10]. Similarly, Byeon
et al. reported that in a ≥60-year-old Korean study popula-
tion, sarcopenic individuals defined by weight-adjusted
ASM had a higher Framingham risk score than non-
sarcopenic individuals in a non-obese group [11]. Moreover,
in a Thai population, Pongchaiyakul et al. found that an
urban environment is the strongest predictive factor for
sarcopenia defined by weight-adjusted ASM, followed by
high body mass index (BMI) and age [12]. These previous
studies suggest that the relationship between sarcopenia
and the risk of lifestyle-related diseases such as cardiometa-
bolic diseases and osteoporosis depends on the method
used to normalize muscle mass in Asian populations.
Lim et al. previously compared risk factors for meta-
bolic syndrome in Korean individuals with sarcopenia
defined by height-adjusted and weight-adjusted ASM
[13]. In that study, however, the sex-specific young refer-
ence group used to determine cut-off points for sarcope-
nia had a small number of subjects.
Although Sanada et al. reported reference values for
height-adjusted ASM in sarcopenia for young Japanese
adult men and women [14], it is unclear whether differ-
ent relationships would result between sarcopenia de-
fined by height-adjusted ASM or weight-adjusted ASM
and risk factors for cardiometabolic diseases or osteo-
porosis in Japanese populations.
Against this backdrop, this study aimed to compare
relationships between height- or weight-adjusted ASM
and risk factors for cardiometabolic diseases or osteo-
porosis in Japanese men and women.
Methods
Subjects
Subjects were healthy Japanese men (n = 583) and women
(n = 1218) aged 18–90 years. The study population included
a young group (310 men and 357 women; age, 18–40 years)
which served as a basis to define the reference values
referred by Baumgartner et al. [2], and a middle-aged and
elderly group (273 men and 861 women; age, ≥41 years).
The subjects were recruited from people participating in a
Nutrition and Exercise Intervention Study (NEXIS, regis-
tered at ClinicalTrials.gov, Identifier: NCT00926744). We
excluded men and women with obesity (BMI ≥25), CVD,
and stroke, as determined using a medical history question-
naire. They were sedentary or moderately active and partic-
ipated in a swimming, stretching, and “healthy gymnastics”
program; however, none of the subjects participated in
other vigorous sports activities. The purpose, procedures,
and risks of the study were explained to all participants
prior to inclusion, and all subjects gave their written in-
formed consent before enrolling in the study. The study
was performed in accordance with the guidelines of the
Declaration of Helsinki and was approved by the Human
Research Committee of the National Institute of Health
and Nutrition, Tokyo, Japan (KENEI14-02). Body weight
and height were recorded, and BMI was calculated as
weight (kg) divided by the square of the height (m). Waist
circumference (WC) was measured at the uppermost
border of the iliac crests.
Analysis of blood samples
Blood was drawn from subjects in the seated position. Fast-
ing (>12 h) blood samples were collected by venipuncture
in tubes with or without ethylene diamine tetraacetic acid
(for plasma or serum). Blood samples were centrifuged at
1500 rpm for 15 min and stored at –20 °C. Serum concen-
tration of triglycerides (TG) was determined using com-
mercial kits (Mitsubishi Chemical Medience, Tokyo, Japan).
Serum high-density lipoprotein cholesterol (HDL-C) was
measured by an enzymatic method (Mitsubishi Chemical
Medience). Whole-blood glycohemoglobin A1c (HbA1c)
was measured by an enzymatic method (glycohemoglobin
A1c kit; Mitsubishi Chemical Medience).
Analysis of arterial blood pressure at rest
Systolic blood pressure (SBP) and diastolic blood pressure
(DBP) were measured at rest using a vascular testing
device (Colin Medical Technology, Tokyo, Japan). Chronic
arterial blood pressure levels at rest were measured with
the same device over the brachial and dorsalis pedis arter-
ies. Recordings were made in triplicate with subjects in
the supine position. Brachial-ankle pulse wave velocity
(baPWV), which provides qualitatively similar information
to that derived from central arterial stiffness, was mea-
sured by the volume plethysmographic method.
Whole-body dual-energy X-ray absorptiometry
Lean soft tissue mass and BMD were determined by
whole-body dual-energy X-ray absorptiometry (DXA)
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(Hologic QDR-4500A scanner; Hologic, Waltham, MA).
Whole-body lean soft tissue mass was divided into
several regions, i.e., the arms, legs, and trunk. Body com-
position was determined by Hologic software version
11.2:3 for Windows (Hologic, Waltham, MA). The refer-
ence values (ASM/Ht2, ASM/Wt × 100) for class 1 and
class 2 sarcopenia in each sex were defined as values one
and two standard deviations (SD) below the sex-specific
means of the reference data for young adults aged
18–40 years, respectively.
Measures of fitness
Handgrip strength of the right upper limb was measured
using a handheld dynamometer. In the standing position,
with the arm straight by the side, the subjects gripped the
dynamometer as hard as possible for 3 s without pressing
the instrument against the body or bending at the elbow.
Value was recorded as the average of two trials.
Statistical analysis
All measurements and calculated values are expressed as
mean ± SD. Partial correlations between height-adjusted
ASM and weight-adjusted ASM were analyzed after
adjusting for age and percent body fat. Differences be-
tween prevalence of sarcopenia defined by height-adjusted
ASM and weight-adjusted ASM were assessed by the chi-
square test. We compared mean values of physical cha-
racteristics, body composition, fitness, and risk factors for
cardiometabolic diseases between normal, class 1 and
class 2 sarcopenia by one-way ANCOVA after adjusting
for age and percent body fat. Student’s unpaired t test was
used to test differences among normal, class 1 and class 2
sarcopenic subjects. The alpha level for testing signifi-
cance was set at P < 0.05. All statistical analyses were
performed using StatView version 5.0 for Window (SAS
Institute, Cary, NC, USA).
Results
The physical characteristics of young group and middle-
aged and elderly group are shown in Table 1. Height-
adjusted ASM in young men and women aged 18–40 years
were 8.66 ± 0.89 kg/m2 and 6.80 ± 0.75 kg/m2, respectively.
Weight-adjusted ASM in young men and women were
38.1 ± 3.0% and 32.7 ± 3.2%, respectively. Therefore, in this
study, the cut-off values for class 1 sarcopenia using height-
adjusted ASM in men and women were set as 7.77 and
6.06 kg/m2 and the cut-off values for class 2 sarcopenia
were set as 6.89 and 5.31 kg/m2, respectively. In addition,
the cut-off values for class 1 sarcopenia using weight-
adjusted ASM in men and women were set as 35.0 and
29.6% and the cut-off values for class 2 sarcopenia were set
as 32.0 and 26.4%, respectively. In the middle-aged and
elderly group aged 41–90 years, height-adjusted ASM in
men and women were 8.05 ± 0.68 kg/m2 and 6.47 ±
0.58 kg/m2, respectively. Weight-adjusted ASM in men and
women were 35.9 ± 2.6% and 30.3 ± 2.9%, respectively.
Partial correlation coefficients adjusted for age are
shown in Table 2. After adjusting for age, partial cor-
relation coefficients between height-adjusted ASM and
weight-adjusted ASM were 0.577 in men (P < 0.001) and
0.467 in women (P < 0.001), and Wt, BMI, and WC were
positively correlated with height-adjusted ASM but
negatively correlated with weight-adjusted ASM in men
and women (P < 0.01). HbA1c, TG, SBP, and DBP were
negatively, and HDL-C was positively, correlated with
weight-adjusted ASM (P < 0.01), but not with height-
adjusted ASM in women. In men, lumbar spine BMD
was positively correlated with ASM/Ht2 (P < 0.05), but
not with ASM/Wt. ASM/Ht2 had higher correlation
coefficients with whole-body, arm, lumber spine, and leg
BMD than ASM/Wt in both men and women. In men
and women, baPWV was negatively correlated with both
ASM/Ht2 and ASM/Wt (P < 0.05).
Table 1 Physical characteristics of young group and middle-aged and elderly group
Young group Middle-aged and elderly group
Men Women Men Women
Number 310 357 273 861
Age (years) 29 ± 7 29 ± 7 60 ± 12 60 ± 11
Height (cm) 173.2 ± 5.6 160.4 ± 5.9 168.7 ± 6.3 155.7 ± 5.8
Weight (kg) 68.6 ± 8.8 53.9 ± 7.2 63.9 ± 6.7 52.0 ± 5.8
BMI (kg/m2) 22.9 ± 2.8 20.9 ± 2.5 22.4 ± 1.5 21.4 ± 1.9
WC (cm) 79.2 ± 7.9 73.0 ± 8.4 82.1 ± 5.6 79.6 ± 7.2
Percent body fat (%) 16.7 ± 4.8 24.4 ± 5.7 20.0 ± 3.9 28.0 ± 5.2
Handgrip strength (kg) 44.5 ± 7.1 29.3 ± 5.3 38.6 ± 7.3 25.1 ± 4.5
ASM/Ht2 (kg/m2) 8.66 ± 0.89 6.80 ± 0.75 8.05 ± 0.68 6.47 ± 0.58
ASM/Wt × 100 (%) 38.1 ± 3.0 32.7 ± 3.2 35.9 ± 2.6 30.3 ± 2.9
Data are presented as mean ± SD
BMI body mass index, WC waist circumference, ASM appendicular skeletal muscle mass, Ht height, Wt weight
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Partial correlation coefficients adjusted for age and
percent body fat are shown in Table 3. After adjusting
for age and percent body fat, partial correlation co-
efficients between height-adjusted ASM and weight-
adjusted ASM were 0.630 in men (P < 0.001) and 0.577
in women (P < 0.001). HbA1c, TG, and TG/HDL-C were
not significantly correlated with ASM/Ht2 and ASM/Wt
in both men and women. In men, whole-body, arm,
lumbar spine, and leg BMD were positively correlated
with ASM/Ht2 (P < 0.05), but not with ASM/Wt. In
women, whole-body and lumbar spine BMD were posi-
tively correlated with ASM/Ht2 (P < 0.001), but not with
ASM/Wt. In men and women, baPWV was negatively
correlated with both ASM/Ht2 and ASM/Wt (P < 0.001).
When sarcopenia was defined by weight-adjusted
ASM, the prevalence rates of class 1 and class 2 sarcope-
nia in the subjects aged 41–90 years were 32.6% (89/
273) and 5.9% (16/273) in men (Table 4) and 35.5%
(306/861) and 7.1% (61/861) in women (Table 5), re-
spectively. When defined by height-adjusted ASM, the
prevalence rates of class 1 and class 2 sarcopenia in the
subjects aged 41–90 years were 27.8% (76/273) and 4.4%
(12/273) in men (Table 4) and 22.3% (192/861) and 1.5%
(13/861) in women (Table 5), respectively. The prevalence
rates of sarcopenia significantly differed when defined by
height-adjusted ASM and weight-adjusted ASM in both
men and women (P < 0.001; chi-square test). In the sub-
jects aged 65–90 years, the prevalence rates of class 1 and
class 2 sarcopenia defined by weight-adjusted ASM were
39.8% (43/108) and 10.2% (11/108) in men, and 39.8%
(125/314) and 9.2% (29/314) in women, respectively.
When defined by height-adjusted ASM, the prevalence
rates of class 1 and class 2 sarcopenia were 39.8% (43/108)
and 9.3% (10/108) in men and 24.2% (76/314) and 2.5%
(8/314) in women, respectively.
Health-related indexes of middle-aged and elderly
men (age ≥41 years) are shown in Table 4. When sar-
copenia was defined by height-adjusted ASM, BMI
and WC in class 1 and class 2 sarcopenic subjects
were significantly lower than those in normal subjects
(P < 0.05), but when sarcopenia was defined by weight-
adjusted ASM, BMI and WC did not significantly dif-
fer between the three groups. Whole-body BMD, arm
BMD, lumbar spine BMD, and leg BMD in class 1 and
2 sarcopenic subjects defined by height-adjusted ASM
were significantly lower than those in normal subjects
(P < 0.05). When sarcopenia was defined by weight-
adjusted ASM, those in class 1 and 2 sarcopenic
Table 2 Partial correlation coefficients adjusted for age between ASM and measured values in middle-aged and elderly
men and women
Men Women
ASM/Ht2 (kg/m2) ASM/Wt × 100 (%) ASM/Ht2 (kg/m2) ASM/Wt × 100 (%)
R P value R P value R P value R P value
ASM/Ht2 (kg/m2) – – 0.577 <0.001 – – 0.467 <0.001
ASM/Wt × 100 (%) 0.577 <0.001 – – 0.467 <0.001 – –
Height (cm) 0.086 N.S. 0.097 <0.01 0.039 N.S. 0.148 <0.001
Weight (kg) 0.427 <0.001 −0.199 <0.01 0.431 <0.001 −0.373 <0.001
BMI (kg/m2) 0.538 <0.001 −0.374 <0.001 0.478 <0.001 −0.549 <0.001
WC (cm) 0.198 <0.01 −0.485 <0.001 0.209 <0.001 −0.558 <0.001
Percent body fat (%) −0.239 <0.001 −0.729 <0.001 −0.251 <0.001 −0.896 <0.001
Handgrip strength (kg) 0.383 <0.001 0.394 <0.001 0.340 <0.001 0.283 <0.001
Whole-body BMD (g/cm2) 0.352 <0.001 0.139 <0.05 0.275 <0.001 0.207 <0.001
Arm BMD (g/cm2) 0.422 <0.001 0.190 <0.01 0.324 <0.001 0.249 <0.001
Lumbar spine BMD (g/cm2) 0.206 <0.05 0.080 N.S. 0.244 <0.001 0.150 <0.001
Leg BMD (g/cm2) 0.442 <0.001 0.167 <0.01 0.378 <0.001 0.174 <0.001
HbA1c (%) −0.032 N.S. 0.019 N.S. 0.009 N.S. −0.104 <0.01
TG (mg/dl) −0.032 N.S. −0.153 <0.05 −0.045 N.S. −0.224 <0.001
HDL-C (mg/dl) 0.051 N.S. 0.246 <0.001 0.001 N.S. 0.333 <0.001
TG/HDL ratio −0.033 N.S. −0.179 <0.05 −0.039 N.S. −0.268 <0.001
SBP (mmHg) 0.060 N.S. −0.011 N.S. 0.035 N.S. −0.114 <0.01
DBP (mmHg) 0.141 <0.05 −0.039 N.S. 0.034 N.S. −0.127 <0.001
baPWV (cm/s) −0.214 <0.01 −0.149 <0.05 −0.153 <0.001 −0.141 <0.001
ASM appendicular skeletal muscle mass, Ht height, Wt weight, BMI body mass index, WC waist circumference, BMD bone mineral density, HbA1c glycohemoglobin A1c,
TG triglycerides, HDL-C high-density lipoprotein cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure, baPWV brachial-ankle pulse wave velocity
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subjects were not significantly different. When sarco-
penia was defined by weight-adjusted ASM, baPWV in
class 1 and 2 sarcopenic subjects was significantly higher
than that in normal subjects (P < 0.05), but when defining
sarcopenia by height-adjusted ASM, that was not signifi-
cantly different.
Health-related indexes in middle-aged and elderly
women are shown in Table 5. In height-adjusted defin-
ition, BMI, WC, and handgrip strength in class 1 and
2 sarcopenic subjects were significantly lower than
those in normal subjects (P < 0.05), but not in weight-
adjusted definition. When sarcopenia was defined by
height-adjusted ASM, whole-body BMD, arm BMD,
lumbar spine BMD, and leg BMD in class 1 and class
2 sarcopenic subjects were significantly lower than
those in normal subjects (P < 0.05), but when sarcope-
nia was defined by weight-adjusted ASM, those were
not significantly different. In definition of ASM/Wt,
TG, TG/HDL-C, SBP, and DBP in class 1 and class 2
sarcopenic subjects were significantly higher than
those in normal subjects (P < 0.05), but in definition of
ASM/Ht2, those were not significantly different. In
both definitions, baPWV in class 1 and 2 sarcopenic
subjects was significantly higher than that in normal
subjects (P < 0.05).
Discussion
The major findings of our study were that height-
adjusted ASM showed stronger associations with risk
factors for osteoporosis than weight-adjusted ASM, and
conversely, weight-adjusted ASM was more strongly as-
sociated with risk factors for cardiometabolic diseases
than height-adjusted ASM.
Kim et al. previously proposed cut-off values for class
1 and class 2 sarcopenia in Korean people [15] of 32.2
and 29.1% for men and 25.6 and 23.0% for women, re-
spectively, using the weight-adjusted definition. They
also reported prevalence rates of class 1 and class 2
sarcopenia of 29.5 and 9.7% for elderly men and 30.3
and 11.8% for elderly women (age, ≥65 years), respect-
ively, using the same definition. In this study, the pre-
valence rates of sarcopenia were higher than those
reported in the Korean study for both sexes and our cut-
off values were considerably higher because weight,
BMI, and WC in our young group were lower than those
in the young group from the Korean study. Moreover,
absolute muscle mass in our young group was relatively
higher than that reported in the Korean study.
Sanada et al. previously reported that BMI and WC in
sarcopenic subjects (defined by height-adjusted ASM)
were significantly lower than those in normal subjects
Table 3 Partial correlation coefficients adjusted for age and percent body fat between ASM and measured values in middle-aged
and elderly men and women
Men Women
ASM/Ht2 (kg/m2) ASM/Wt × 100 (%) ASM/Ht2 (kg/m2) ASM/Wt × 100 (%)
R P value R P value R P value R P value
ASM/Ht2 (kg/m2) – – 0.630 <0.001 – – 0.577 <0.001
ASM/Wt × 100 (%) 0.630 <0.001 – – 0.577 <0.001 – –
Height (cm) 0.036 N.S. 0.166 <0.05 0.029 N.S. 0.250 <0.001
Weight (kg) 0.605 <0.001 0.266 <0.001 0.679 <0.001 0.277 <0.001
BMI (kg/m2) 0.889 <0.001 0.211 <0.01 0.870 <0.001 0.113 <0.01
WC (cm) 0.499 <0.001 0.162 <0.05 0.477 <0.001 0.092 <0.05
Handgrip strength (kg) 0.287 <0.001 0.188 <0.01 0.278 <0.001 0.167 <0.001
Whole-body BMD (g/cm2) 0.306 <0.001 −0.026 N.S. 0.217 <0.001 0.028 N.S.
Arm BMD (g/cm2) 0.366 <0.001 0.041 N.S. 0.282 <0.001 0.171 <0.001
Lumbar spine BMD (g/cm2) 0.150 <0.05 −0.137 <0.05 0.206 <0.001 −0.018 N.S.
Leg BMD (g/cm2) 0.414 <0.001 0.082 N.S. 0.360 <0.001 0.203 <0.001
HbA1c (%) −0.040 N.S. −0.031 N.S. 0.056 N.S. 0.000 N.S.
TG (mg/dl) −0.033 N.S. 0.012 N.S. 0.031 N.S. −0.003 N.S.
HDL-C (mg/dl) −0.003 N.S. −0.114 N.S. −0.093 <0.05 0.036 N.S.
TG/HDL ratio −0.018 N.S. 0.060 N.S. 0.046 N.S. −0.024 N.S.
SBP (mmHg) 0.068 N.S. −0.069 N.S. 0.077 <0.05 −0.057 N.S.
DBP (mmHg) 0.157 <0.05 0.007 N.S. 0.073 <0.05 −0.087 <0.05
baPWV (cm/s) −0.240 <0.001 −0.241 <0.001 −0.133 <0.001 −0.152 <0.001
ASM appendicular skeletal muscle mass, Ht height, Wt weight, BMI body mass index, WC waist circumference, BMD bone mineral density, HbA1c glycohemoglobin A1c,
TG triglycerides, HDL-C high-density lipoprotein cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure, baPWV brachial-ankle pulse wave velocity
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[14]. Abe et al. also reported that, after adjusting for age,
BMI, WC, and percent body fat were lower when using
the height-adjusted definition [16]. This suggests that
sarcopenia defined by height-adjusted ASM does not
detect people at higher risk of obesity. However, Janssen
et al. found that sarcopenia defined by weight-adjusted
ASM was associated with higher BMI in both men and
women [7]. In the present study, when sarcopenia was
defined by height-adjusted ASM, WC in sarcopenic sub-
jects was significantly lower than that in normal subjects
(P < 0.05), but when defined by weight-adjusted ASM,
WC was not significantly different for both men (Table 4)
and women (Table 5). Moreover, Wt, BMI, and WC
were positively correlated with height-adjusted ASM, but
negatively correlated with weight-adjusted ASM after
adjusting for age in both men and women (Table 2).
These results suggest that sarcopenia defined by weight-
adjusted ASM is associated with abdominal obesity.
Thus, defining sarcopenia by weight-adjusted ASM
can better detect sarcopenic individuals at higher risk
of obesity than when defining sarcopenia by height-
adjusted ASM.
Recently, Hamasaki et al. reported that the ratio of
lower extremity muscle mass to weight measured by
bioelectrical impedance was negatively correlated with
BMI, WC, body fat mass, percent body fat, subcutaneous
fat area, and serum-free fatty acid concentration [17]. In
this study, after adjusting age, ASM/Wt was more
strongly correlated with risk factors for cardiometabolic
diseases than ASM/Ht2 (Table 2). For example, ASM/
Wt was negatively correlated with TG and positively
correlated with HDL-C, but ASM/Ht2 was not corre-
lated with them in both men and women. ASM/Wt was
also strongly correlated with percent body fat (men;
Table 4 Characteristics of middle-aged and elderly men with sarcopenia defined by height-adjusted ASM or weight-adjusted ASM
Sarcopenia defined by ASM/Ht2 Sarcopenia defined by ASM/Wt









Number 185 (67.8%) 76 (27.8%) 12 (4.4%) – – 168 (61.5%) 89 (32.6%) 16 (5.9%) – –
Age (years) 57 ± 10 64 ± 13 70 ± 14 – – 57 ± 11 62 ± 12 69 ± 11 – –
Height (cm) 169.5 ± 6.2 167.5 ± 5.9 164.4 ± 7.4 N.S. 169.2 ± 6.5 168.1 ± 5.8 166.6 ± 6.7 N.S.
Weight (kg) 66.0 ± 5.5 60.5 ± 6.3 53.4 ± 6.5 <0.001 a,b,c 63.5 ± 6.8 64.8 ± 6.1 63.1 ± 8.2 <0.01
BMI (kg/m2) 23.0 ± 1.2 21.5 ± 1.5 19.5 ± 1.4 <0.001 a,b,c 22.1 ± 1.6 22.9 ± 1.3 22.7 ± 1.8 N.S.
WC (cm) 82.9 ± 5.2 81.5 ± 5.8 75.1 ± 5.2 <0.001 a,b,c 80.2 ± 5.1 85.1 ± 4.4 84.9 ± 7.3 N.S.
Percent body
fat (%)
19.7 ± 3.7 20.8 ± 4.2 20.1 ± 4.0 – – 18.1 ± 3.4 22.9 ± 2.0 24.4 ± 3.4 – –
Handgrip
strength (kg)
40.5 ± 7.0 34.9 ± 6.1 31.9 ± 6.5 <0.001 a,b 40.7 ± 6.9 35.5 ± 6.7 33.5 ± 6.1 <0.01 a,b
Whole-body
BMD (g/cm2)
1.142 ± 0.109 1.078 ± 0.084 1.019 ± 0.113 <0.001 a,b 1.133 ± 0.104 1.097 ± 0.107 1.091 ± 0.135 N.S.
Arm BMD
(g/cm2)
0.799 ± 0.059 0.752 ± 0.049 0.713 ± 0.057 <0.001 a,b,c 0.793 ± 0.059 0.766 ± 0.061 0.755 ± 0.061 N.S.
Lumbar spine
BMD (g/cm2)
1.076 ± 0.190 1.012 ± 0.193 0.944 ± 0.223 <0.01 a,b 1.065 ± 0.181 1.027 ± 0.206 1.067 ± 0.261 N.S.
Leg BMD
(g/cm2)
1.246 ± 0.113 1.158 ± 0.088 1.068 ± 0.089 <0.001 a,b,c 1.234 ± 0.117 1.184 ± 0.103 1.176 ± 0.140 N.S.
HbA1c (%) 5.29 ± 0.54 5.45 ± 0.63 5.85 ± 1.11 N.S. 5.32 ± 0.60 5.36 ± 0.54 5.76 ± 0.88 N.S.
TG (mg/dl) 104.2 ± 52.5 100.7 ± 51.3 109.4 ± 46.22 N.S. 96.8 ± 47.0 115.1 ± 59.8 109.5 ± 41.0 N.S.
HDL-C (mg/dl) 59.7 ± 13.7 61.4 ± 15.1 65.1 ± 17.0 N.S. 62.1 ± 14.5 57.4 ± 13.2 59.0 ± 15.9 N.S.
TG/HDL ratio 1.92 ± 1.20 1.83 ± 1.23 1.81 ± 0.86 N.S. 1.73 ± 1.12 2.18 ± 1.33 1.92 ± 0.71 N.S.
SBP (mmHg) 126 ± 14 126 ± 16 127 ± 23 N.S. 125 ± 14 127 ± 15 132 ± 18 N.S.
DBP (mmHg) 80 ± 10 77 ± 11 74 ± 10 <0.05 a 78 ± 10 79 ± 10 82 ± 11 N.S.
baPWV (cm/s) 1402 ± 247 1529 ± 308 1758 ± 399 N.S. 1388 ± 243 1515 ± 278 1773 ± 436 <0.001 a,b,c
Data are presented as mean ± SD
BMI body mass index, WC waist circumference, BMD bone mineral density, HbA1c glycohemoglobin A1c, TG triglycerides, HDL-C high-density lipoprotein choles-
terol, SBP systolic blood pressure, DBP diastolic blood pressure, baPWV brachial-ankle pulse wave velocity
*One-way ANCOVA adjusted for age and percent body fat and post hoc analysis using the least significant difference t test (mean difference between two
groups): a, Normal vs. class 1; b, Normal vs. class 2; c, class 1 vs. class 2; all P < 0.05
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R = −0.73, women; R = −0.90). Thus, it is considered
that the associations between ASM/Wt and risk factors
for cardiometabolic diseases were caused by negative cor-
relations between ASM/Wt and percent body fat. After
adjusting age and percent body fat, most of the significant
differences were disappeared (Table 3). Therefore, it was
shown that percent body fat contributed strongly to the
associations between ASM/Wt and risk factors for cardio-
metabolic diseases. However, even after adjusting age and
percent body fat, sarcopenia defined by weight-adjusted
ASM in women was significantly associated with risk
factors for cardiometabolic diseases, including TG, TG/
HDL-C, SBP, and DBP (Table 5). On the other hand, sar-
copenia defined by height-adjusted ASM was not signifi-
cantly associated with them. For men, in definition of
ASM/Wt, baPWV in sarcopenic subjects was significantly
higher than that in normal subjects, but in definition of
ASM/Ht2, baPWV was not significantly different (Table 4).
These results suggested that even after adjusting percent
body fat, sarcopenia defined by weight-adjusted ASM can
detect sarcopenic individuals at higher risk of cardiometa-
bolic diseases with more sensitivity than when defined by
height-adjusted ASM.
With regard to risk factors for osteoporosis, a previous
study reported that sarcopenia defined by height-adjusted
ASM was associated with lower BMD in both men and
women [14]. In contrast, another study reported that
osteoporosis was not significantly associated with muscle
mass/weight [12]. In the present study, for both men and
women, whole-body BMD, arm BMD, lumbar spine BMD,
and leg BMD in sarcopenic subjects (defined by height-
adjusted ASM) were significantly lower than those for
normal subjects. When defined by weight-adjusted ASM,
however, those in sarcopenic subjects were not signifi-
cantly different (Tables 4 and 5). These results suggest that
sarcopenia defined by height-adjusted ASM can better
Table 5 Characteristics of middle-aged and elderly women with sarcopenia defined by height-adjusted ASM or
weight-adjusted ASM
Sarcopenia defined by ASM/Ht2 Sarcopenia defined by ASM/Wt









Number 656 (76.2%) 192 (22.3%) 13 (1.5%) – – 494 (57.4%) 306 (35.5%) 61 (7.1%) – –
Age (years) 60 ± 11 62 ± 11 67 ± 11 – – 59 ± 11 62 ± 10 64 ± 10 – –
Height (cm) 155.9 ± 5.9 155.3 ± 5.7 152.8 ± 5.8 N.S. 156.6 ± 5.9 154.6 ± 5.6 153.7 ± 5.7 <0.01 a,b
Weight (kg) 53.1 ± 5.5 48.6 ± 5.0 44.4 ± 5.5 <0.001 a,b,c 50.8 ± 5.8 53.3 ± 5.5 55.1 ± 4.8 <0.001 a,b,c
BMI (kg/m2) 21.9 ± 1.8 20.1 ± 1.8 18.9 ± 1.9 <0.001 a,b,c 20.7 ± 1.8 22.3 ± 1.6 23.3 ± 1.3 N.S.
WC (cm) 80.4 ± 6.9 77.5 ± 7.3 74.7 ± 7.3 <0.001 a,b,c 76.7 ± 6.3 82.7 ± 6.1 87.1 ± 6.5 N.S.
Percent body
fat (%)
27.5 ± 5.2 29.3 ± 5.0 30.6 ± 5.4 – – 24.8 ± 4.1 31.4 ± 2.6 36.1 ± 2.4 – –
Handgrip
strength (kg)
25.7 ± 4.5 23.3 ± 3.7 19.7 ± 4.3 <0.001 a,b,c 26.1 ± 4.6 23.9 ± 3.8 22.4 ± 4.1 N.S.
Whole-body
BMD (g/cm2)
1.003 ± 0.117 0.956 ± 0.102 0.883 ± 0.112 <0.001 a,b,c 1.012 ± 0.119 0.965 ± 0.106 0.945 ± 0.093 N.S.
Arm BMD (g/cm2) 0.633 ± 0.067 0.605 ± 0.058 0.561 ± 0.064 <0.001 a,b,c 0.640 ± 0.070 0.609 ± 0.057 0.598 ± 0.050 N.S.
Lumbar spine
BMD (g/cm2)
0.952 ± 0.174 0.888 ± 0.156 0.747 ± 0.166 <0.001 a,b,c 0.961 ± 0.181 0.902 ± 0.157 0.885 ± 0.144 N.S.
Leg BMD (g/cm2) 1.026 ± 0.106 0.97 ± 0.095 0.884 ± 0.104 <0.001 a,b,c 1.030 ± 0.112 0.990 ± 0.095 0.968 ± 0.082 N.S.
HbA1c (%) 5.38 ± 0.52 5.43 ± 0.53 5.36 ± 0.52 N.S. 5.31 ± 0.41 5.48 ± 0.64 5.56 ± 0.57 N.S.
TG (mg/dl) 82.6 ± 39.6 88.0 ± 46.1 90.2 ± 45.7 N.S. 76.0 ± 34.6 90.9 ± 44.5 112.5 ± 54.5 <0.05 a,b,c
HDL-C (mg/dl) 71.3 ± 16.8 70.2 ± 15.3 72.5 ± 15.8 N.S. 75.0 ± 16.9 66.8 ± 14.4 61.3 ± 14.3 N.S.
TG/HDL ratio 1.29 ± 0.92 1.39 ± 1.05 1.47 ± 1.05 N.S. 1.11 ± 0.71 1.52 ± 1.11 2.00 ± 1.32 <0.05 a,b,c
SBP (mmHg) 120 ± 17 122 ± 20 120 ± 19 N.S. 118 ± 17 123 ± 18 130 ± 20 <0.05 a,b,c
DBP (mmHg) 71 ± 10 72 ± 12 69 ± 11 N.S. 70 ± 10 72 ± 10 75 ± 12 <0.05 a,b,c
baPWV (cm/s) 1319 ± 239 1433 ± 313 1607 ± 316 <0.001 a,b,c 1306 ± 245 1386 ± 270 1512 ± 301 <0.01 a,b,c
Data are presented as mean ± SD
BMI body mass index, WC waist circumference, BMD bone mineral density, HbA1c glycohemoglobin A1c, TG triglycerides, HDL-C high-density lipoprotein choles-
terol, SBP systolic blood pressure, DBP diastolic blood pressure, baPWV brachial-ankle pulse wave velocity
*One-way ANCOVA adjusted for age and percent body fat and post hoc analysis using the least significant difference t test (mean difference between two
groups): a, Normal vs. class 1; b, Normal vs. class 2; c, class 1 vs. class 2; all P < 0.05
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detect sarcopenic individuals at higher risk of osteoporosis
than when defined by weight-adjusted ASM. However,
this study measured whole-body and regional BMD using
only whole-body DXA. Lumbar spine BMD should be
examined by the specific manner. This point is a limita-
tion in the present study.
Conclusions
In practice, the use of height-adjusted ASM has the advan-
tage over the weight-adjusted ASM to detect risk factors
for osteoporosis. Conversely, the use of weight-adjusted
ASM has the advantage to detect risk factors for cardiomet-
abolic diseases.
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